Heart Disease Trial, Recruiting NCT06529848 Sponsor: Bispebjerg Hospital Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06529848
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been found to have poor blood flow through the small vessels of the heart (called coronary microvascular dysfunction), based on a specific type of heart scan called a PET scan
  • People who do not have significant blockages in their major heart arteries

Who may not be able to join:

  • Women who are of childbearing age and could become pregnant — only women who have gone through menopause (no periods for at least one year) or who have had a surgical procedure making them unable to become pregnant would be considered
  • People with heart failure, meaning their heart's pumping function is significantly reduced
  • People with high blood pressure that is not well controlled (blood pressure above 140/90)
  • People with a serious illness or condition that means they are not expected to live for more than one year
  • People the trial doctor considers unsuitable for the study for any reason
  • People who are unable or unwilling to exercise — for example, due to arthritis or an injury
  • People who are already regularly physically active or who have a high fitness level based on an exercise breathing test (confirm with trial site for exact fitness threshold)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Eva Prescott, MD, DMSc, University of Copenhagen

Phone: 004522572614

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Bispebjerg Hospital
Registry
ClinicalTrials.gov
Start date
1 November 2024
Est. completion
30 October 2027

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Change in Myocardial Blood Flow Reserve (MBFR)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov